IL139493A0 - Adenosine a3 receptor modulators - Google Patents
Adenosine a3 receptor modulatorsInfo
- Publication number
- IL139493A0 IL139493A0 IL13949399A IL13949399A IL139493A0 IL 139493 A0 IL139493 A0 IL 139493A0 IL 13949399 A IL13949399 A IL 13949399A IL 13949399 A IL13949399 A IL 13949399A IL 139493 A0 IL139493 A0 IL 139493A0
- Authority
- IL
- Israel
- Prior art keywords
- adenosine
- receptor modulators
- modulators
- receptor
- Prior art date
Links
- 102000008161 Adenosine A3 Receptor Human genes 0.000 title 1
- 108010060261 Adenosine A3 Receptor Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL15685199A IL156851A0 (en) | 1998-09-16 | 1999-09-15 | Adenosine a3 receptor modulators |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/154,435 US6448253B1 (en) | 1998-09-16 | 1998-09-16 | Adenosine A3 receptor modulators |
US09/379,300 US6407236B1 (en) | 1998-09-16 | 1999-08-23 | Adenosine A3 receptor modulators |
PCT/US1999/021103 WO2000015231A1 (en) | 1998-09-16 | 1999-09-15 | Adenosine a3 receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
IL139493A0 true IL139493A0 (en) | 2001-11-25 |
Family
ID=26851445
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13949399A IL139493A0 (en) | 1998-09-16 | 1999-09-15 | Adenosine a3 receptor modulators |
IL15685299A IL156852A0 (en) | 1998-09-16 | 1999-09-15 | Adenosine a3 receptor modulators |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15685299A IL156852A0 (en) | 1998-09-16 | 1999-09-15 | Adenosine a3 receptor modulators |
Country Status (1)
Country | Link |
---|---|
IL (2) | IL139493A0 (en) |
-
1999
- 1999-09-15 IL IL13949399A patent/IL139493A0/en unknown
- 1999-09-15 IL IL15685299A patent/IL156852A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL156852A0 (en) | 2004-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2353527B (en) | Adenosine A3 receptor modulators | |
IL150912A0 (en) | Adenosine receptor modulators | |
EP1019427A4 (en) | N?6 -substituted-adenosine-5'-uronamides as adenosine receptor modulators | |
IL135966A0 (en) | Adenosine a1 receptor agonists | |
IL135965A0 (en) | Adenosine a1 receptor agonists | |
IL135964A0 (en) | Adenosine a1 receptor agonists | |
IL133920A0 (en) | Trail receptor | |
AU7132898A (en) | Edg-1-like receptor | |
GB9517098D0 (en) | Receptor | |
GB9617923D0 (en) | Novel receptor | |
EP1084142A4 (en) | Gpr35a receptor | |
AU4980999A (en) | A3 adenosine receptor antagonists | |
EP0973800A4 (en) | Novel receptor | |
GB9819420D0 (en) | Novel receptor | |
EP1083909A4 (en) | hCEPR RECEPTOR | |
EP1071766A4 (en) | HUMAN G-PROTEIN COUPLED RECEPTOR GPR6sb | |
EP1092017A4 (en) | Novel gaba-b receptor | |
GB9827016D0 (en) | Receptor protein | |
IL156852A0 (en) | Adenosine a3 receptor modulators | |
IL156851A0 (en) | Adenosine a3 receptor modulators | |
EP1092021A4 (en) | Npy-y7 receptor gene | |
EP1109565A4 (en) | Gabab1aa receptor | |
GB2338999B (en) | Fixing means | |
EP0859787A4 (en) | G-protein coupled receptor hnfds78 | |
GB9825849D0 (en) | Receptor |